Detalhe da pesquisa
1.
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer.
Ann Oncol
; 32(9): 1148-1156, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34116144
2.
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer.
Ann Oncol
; 31(3): 377-386, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32067679
3.
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
Ann Oncol
; 30(11): 1784-1795, 2019 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31591636
4.
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer.
Ann Oncol
; 29(12): 2334-2340, 2018 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30307466
5.
Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study.
Eur J Cancer Care (Engl)
; 27(1)2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28833787
6.
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab.
Ann Oncol
; 28(1): 103-109, 2017 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28177480
7.
Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review.
Breast Cancer Res Treat
; 164(3): 505-513, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28488143
8.
Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study.
Ann Oncol
; 27(9): 1725-32, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27436849
9.
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1).
Ann Oncol
; 27(5): 812-8, 2016 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27052658
10.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Ann Oncol
; 26(5): 873-879, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25725046
11.
Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial.
ESMO Open
; 9(5): 103443, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38692082
12.
Circulating tumor cells and brain metastasis outcome in patients with HER2-positive breast cancer: the LANDSCAPE trial.
Ann Oncol
; 24(12): 2999-3004, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24013510
13.
[Women with a very high risk of breast cancer: Contraceptives, hormonal replacement therapy use and personalized screening]. / Femmes à très haut risque de cancer du sein : contraception, traitement hormonal substitutif et dépistage personnalisé.
Gynecol Obstet Fertil Senol
; 51(5): 275-283, 2023 05.
Artigo
Francês
| MEDLINE | ID: mdl-36924927
14.
Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings.
Cancer Med
; 12(16): 16889-16895, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37409516
15.
Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2.
Br J Cancer
; 106(4): 673-7, 2012 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-22240778
16.
First-line bevacizumab-containing therapy for breast cancer: results in patients aged≥70 years treated in the ATHENA study.
Ann Oncol
; 23(1): 111-118, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-21444356
17.
Is there a role for locoregional treatment of the primary tumor in de novo metastatic breast cancer in the era of tailored therapies?: Evidences, unresolved questions and a practical algorithm.
Crit Rev Oncol Hematol
; 157: 103146, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33227574
18.
De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis.
Eur J Cancer
; 158: 181-188, 2021 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-34689042
19.
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME).
ESMO Open
; 6(4): 100220, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34303929
20.
Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database.
ESMO Open
; 6(3): 100150, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33984675